Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    11352951 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Prospective Study of UDP-gluconoryltransferase 2B17 Genotype as a Predictive Marker of Exemestane PK and PD
Condition: Breast Carcinoma
Intervention: Drug: Exemestane

Indicates status has not been verified in more than two years